FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 322:1622-1627 June 7, 1990 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Tumor necrosis factor has been implicated in the activation of blood coagulation in septicemia, a condition commonly associated with intravascular coagulation and disturbances of hemostasis. To evaluate the early dynamics and the route of the in vivo coagulative response to tumor necrosis factor, we performed a controlled study in six healthy men, monitoring the activation of the common and intrinsic pathways of coagulation with highly sensitive and specific radioimmunoassays. Recombinant human tumor necrosis factor, administered as an intravenous bolus injection (50 micrograms per square meter of body-surface area), induced an early and short-lived rise in circulating levels of the activation peptide of factor X, reaching maximal values after 30 to 45 minutes (mean +/- SEM increase after 45 minutes, 34.2 +/- 18.2 percent; tumor necrosis factor vs. saline, P = 0.015). This was followed by a gradual and prolonged increase in the plasma concentration of the prothrombin fragment F1+2, peaking after four to five hours (mean increase after five hours, 348.0 +/- 144.8 percent; tumor necrosis factor vs. saline, P less than 0.0001). These findings signify the formation of factor Xa (activated factor X) and the activation of prothrombin. Activation of the intrinsic pathway could not be detected by a series of measurements of the plasma levels of factor XII, prekallikrein, factor XIIa-C1 inhibitor complexes, kallikrein-C1 inhibitor complexes, and the activation peptide of factor IX. The delay between the maximal activation of factor X and that of prothrombin amounted to several hours, indicating that neutralization of factor Xa activity was slow. We conclude that a single injection of tumor necrosis factor elicits a rapid and sustained activation of the common pathway of coagulation, probably induced through the extrinsic route. Our results suggest that tumor necrosis factor could play an important part in the early activation of the hemostatic mechanism in septicemia.

Source Information

Department of Internal Medicine, University of Amsterdam, The Netherlands.

This article has been cited by other articles:

• Bradfield, P. F., Johnson-Leger, C. A., Zimmerli, C., Imhof, B. A. (2008). LPS differentially regulates adhesion and transendothelial migration of human monocytes under static and flow conditions. Int Immunol 20: 247-257 [Abstract] [Full Text]  
• Mullarky, I. K., Szaba, F. M., Berggren, K. N., Kummer, L. W., Wilhelm, L. B., Parent, M. A., Johnson, L. L., Smiley, S. T. (2006). Tumor Necrosis Factor Alpha and Gamma Interferon, but Not Hemorrhage or Pathogen Burden, Dictate Levels of Protective Fibrin Deposition during Infection. Infect. Immun. 74: 1181-1188 [Abstract] [Full Text]  
• Zeerleder, S., Hack, C. E., Wuillemin, W. A. (2005). Disseminated Intravascular Coagulation in Sepsis. Chest 128: 2864-2875 [Abstract] [Full Text]  
• Sanchez-Cordon, P. J., Nunez, A., Salguero, F. J., Pedrera, M., Fernandez de Marco, M., Gomez-Villamandos, J. C. (2005). Lymphocyte Apoptosis and Thrombocytopenia in Spleen during Classical Swine Fever: Role of Macrophages and Cytokines. Vet Pathol 42: 477-488 [Abstract] [Full Text]  
• Tousoulis, D, Antoniades, C, Bosinakou, E, Kotsopoulou, M, Tsioufis, C, Tentolouris, C, Trikas, A, Pitsavos, C, Stefanadis, C (2005). Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure. Heart 91: 27-31 [Abstract] [Full Text]  
• Schaffner, A., King, C. C., Schaer, D., Guiney, D. G. (2004). Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. J. Leukoc. Biol. 76: 1010-1018 [Abstract] [Full Text]  
• Clark, I. A., Alleva, L. M., Mills, A. C., Cowden, W. B. (2004). Pathogenesis of Malaria and Clinically Similar Conditions. Clin. Microbiol. Rev. 17: 509-539 [Abstract] [Full Text]  
• Paramo, J.A., Orbe, J., Beloqui, O., Benito, A., Colina, I., Martinez-Vila, E., Diez, J. (2004). Prothrombin Fragment 1+2 Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Cardiovascular Disease. Stroke 35: 1085-1089 [Abstract] [Full Text]  
• Shariat-Madar, Z., Schmaier, A. H. (2004). Review: The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis. Innate Immunity 10: 3-13 [Abstract]  
• Toh, C. H., Dennis, M. (2003). Disseminated intravascular coagulation: old disease, new hope. BMJ 327: 974-977 [Full Text]  
• Bryant, A. E. (2003). Biology and Pathogenesis of Thrombosis and Procoagulant Activity in Invasive Infections Caused by Group A Streptococci and Clostridium perfringens. Clin. Microbiol. Rev. 16: 451-462 [Abstract] [Full Text]  
• Chia, S., Qadan, M., Newton, R., Ludlam, C. A., Fox, K. A.A., Newby, D. E. (2003). Intra-Arterial Tumor Necrosis Factor-{alpha} Impairs Endothelium-Dependent Vasodilatation and Stimulates Local Tissue Plasminogen Activator Release in Humans. Arterioscler. Thromb. Vasc. Bio. 23: 695-701 [Abstract] [Full Text]  
• Henriksen, P A, Newby, D E (2003). Therapeutic inhibition of tumour necrosis factor {alpha} in patients with heart failure: cooling an inflamed heart. Heart 89: 14-18 [Abstract] [Full Text]  
• Pastores, S M (2003). Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis. Postgrad. Med. J. 79: 5-10 [Abstract] [Full Text]  
• FONG, I. W. (2002). Infections and their role in atherosclerotic vascular disease. Journal of the American Dental Association 133: 7S-13S [Abstract] [Full Text]  
• Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Penzes, I., Kubler, A., Knaub, S., Keinecke, H.-O., Heinrichs, H., Schindel, F., Juers, M., Bone, R. C., Opal, S. M., for the KyberSept Trial Study Group, (2001). High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial. JAMA 286: 1869-1878 [Abstract] [Full Text]  
• van der Poll, T. (2001). Coagulation and inflammation. Innate Immunity 7: 301-304 [Abstract]  
• Matthay, M. A. (2001). Severe Sepsis -- A New Treatment with Both Anticoagulant and Antiinflammatory Properties. NEJM 344: 759-762 [Full Text]  
• Minnema, M. C., Peters, R. J. G., de Winter, R., Lubbers, Y. P. T., Barzegar, S., Bauer, K. A., Rosenberg, R. D., Hack, C. E., Cate, H. t. (2000). Activation of Clotting Factors XI and IX in Patients With Acute Myocardial Infarction. Arterioscler. Thromb. Vasc. Bio. 20: 2489-2493 [Abstract] [Full Text]  
• Saito, K., Kobayashi, D., Komatsu, M., Yajima, T., Yagihashi, A., Ishikawa, Y., Minami, R., Watanabe, N. (2000). A Sensitive Assay of Tumor Necrosis Factor {alpha} in Sera from Duchenne Muscular Dystrophy Patients. Clin. Chem. 46: 1703-1704 [Full Text]  
• Dri, P., Gasparini, C., Menegazzi, R., Cramer, R., Alberi, L., Presani, G., Garbisa, S., Patriarca, P. (2000). TNF-Induced Shedding of TNF Receptors in Human Polymorphonuclear Leukocytes: Role of the 55-kDa TNF Receptor and Involvement of a Membrane-Bound and Non-Matrix Metalloproteinase. J. Immunol. 165: 2165-2172 [Abstract] [Full Text]  
• Abraham, E. (2000). Coagulation Abnormalities in Acute Lung Injury and Sepsis. Am. J. Respir. Cell Mol. Bio. 22: 401-404 [Full Text]  
• PITTET, D., HARBARTH, S., SUTER, P. M., REINHART, K., LEIGHTON, A., BARKER, C., MACDONALD, F., ABRAHAM, E., the Ro 45-2081 Study Group, (1999). Impact of Immunomodulating Therapy on Morbidity in Patients with Severe Sepsis. Am. J. Respir. Crit. Care Med. 160: 852-857 [Abstract] [Full Text]  
• Levi, M., ten Cate, H. (1999). Disseminated Intravascular Coagulation. NEJM 341: 586-592 [Full Text]  
• Grau, A. J., Brandt, T., Buggle, F., Orberk, E., Mytilineos, J., Werle, E., Conradt, C., Krause, M., Winter, R., Hacke, W. (1999). Association of Cervical Artery Dissection With Recent Infection. Arch Neurol 56: 851-856 [Abstract] [Full Text]  
• Wheeler, A. P., Bernard, G. R. (1999). Treating Patients with Severe Sepsis. NEJM 340: 207-214 [Full Text]  
• UMBERTO MEDURI, G., TOLLEY, E. A., CHINN, A., STENTZ, F., POSTLETHWAITE, A. (1998). Procollagen Types I and III Aminoterminal Propeptide Levels during Acute Respiratory Distress Syndrome and in Response to Methylprednisolone Treatment. Am. J. Respir. Crit. Care Med. 158: 1432-1441 [Abstract] [Full Text]  
• Manten, A., de Winter, R. J., Minnema, M. C., ten Cate, H., Lijmer, J. G., Adams, R., Peters, R. J.G., van Deventer, S. J.H. (1998). Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res 40: 389-395 [Abstract] [Full Text]  
• LEVI, M., van der POLL, T., ten CATE, H., KUIPERS, B., BIEMOND, B. J., JANSEN, H. M., ten CATE, J. W. (1998). Differential Effects of Anti-cytokine Treatment on Bronchoalveolar Hemostasis in Endotoxemic Chimpanzees. Am. J. Respir. Crit. Care Med. 158: 92-98 [Abstract] [Full Text]  
• Papapetropoulos, A., Piccardoni, P., Cirino, G., Bucci, M., Sorrentino, R., Cicala, C., Johnson, K., Zachariou, V., Sessa, W. C., Altieri, D. C. (1998). Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc. Natl. Acad. Sci. USA 95: 4738-4742 [Abstract] [Full Text]  
• Silverstein, R., Norimatsu, M., Morrison, D.C. (1997). Fundamental differences during Gram-positive versus Gram-negative sepsis become apparent during bacterial challenge of D-galactosamine-treated mice. Innate Immunity 4: 173-181 [Abstract]  
• van der Poll, T., Coyle, S. M., Levi, M., Jansen, P. M., Dentener, M., Barbosa, K., Buurman, W. A., Hack, C. E., ten Cate, J. W., Agosti, J. M., Lowry, S. F. (1997). Effect of a Recombinant Dimeric Tumor Necrosis Factor Receptor on Inflammatory Responses to Intravenous Endotoxin in Normal Humans. Blood 89: 3727-3734 [Abstract] [Full Text]  
• Maurer, F., Medcalf, R. L. (1996). Plasminogen Activator Inhibitor Type 2Gene Induction by Tumor Necrosis Factor and Phorbol Ester Involves Transcriptional and Post-transcriptional Events. IDENTIFICATION OF A FUNCTIONAL NONAMERIC AU-RICH MOTIF IN THE 3prime -UNTRANSLATED REGION. J. Biol. Chem. 271: 26074-26080 [Abstract] [Full Text]  
• Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M.H., Benjamin, E., The Soluble TNF Receptor Sepsis Study Group, (1996). Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein. NEJM 334: 1697-1702 [Abstract] [Full Text]  
• Ueda, Y., Kwang Hoon Lee, , Ito, S., Saito, K., Niesen, N., Brentjens, J. R., Gans, R. O.B. (1996). In vivo neutralization of tumor necrosis factor attenuates the generalized Shwartzman reaction in the rabbit. Innate Immunity 3: 67-75 [Abstract]  
• Velthuis, H. t., Jansen, P. G. M., Oudemans-van Straaten, H. M., Sturk, A., Eijsman, L., Wildevuur, C. R. H. (1995). MYOCARDIAL PERFORMANCE IN ELDERLY PATIENTS AFTER CARDIOPULMONARY BYPASS IS SUPPRESSED BY TUMOR NECROSIS FACTOR. J. Thorac. Cardiovasc. Surg. 110: 1663-1669 [Abstract] [Full Text]  
• Grau, A. J., Buggle, F., Steichen-Wiehn, C., Heindl, S., Banerjee, T., Seitz, R., Winter, R., Forsting, M., Werle, E., Bode, C., Nawroth, P.-P., Becher, H., Hacke, W. (1995). Clinical and Biochemical Analysis in Infection-Associated Stroke. Stroke 26: 1520-1526 [Abstract] [Full Text]  
• Steverink, P.J.G.M., Sturk, A., Rutten, V.P.M.G., Wagenaar-Hilbers, J.P.A., Klein, W.R., van der Velden, M.A., Nemeth, F. (1995). Endotoxin, interleukin-6 and tumor necrosis factor concentrations in equine acute abdominal disease: relation to clinical outcome. Innate Immunity 2: 289-299 [Abstract]  
• Parry, G. C. N., Mackman, N. (1995). Transcriptional Regulation of Tissue Factor Expression in Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 15: 612-621 [Abstract] [Full Text]  
• Porat, R., Paddock, H.N., Cominelli, F., Marra, M.N., Scott, R.W., Schwaitzberg, S.D., Dinarello, C.A. (1995). Effects of bactericidal/permeability-increasing protein on endotoxin-induced fever and Escherichia coli-induced shock in rabbits. Innate Immunity 2: 9-18 [Abstract]  
• Cimminiello, C., Arpaia, G., Toschi, V., Rossi, F., Aloisio, M., Motta, A., Bonfardeci, G. (1994). Plasma Levels of Tumor Necrosis Factor and Endothelial Response in Patients with Chronic Arterial Obstructive Disease or Raynaud's Phenomenon. ANGIOLOGY 45: 1015-1022 [Abstract]